The purpose of this research study is to test barzolvolimab (also known as CDX-0159) and to understand the following in approximately 10 healthy male volunteers: • If it stops or slows down the way your body makes new sperm cells and how quickly this occurs • If...
https://chpswtemple.co1.qualtrics.com/jfe/form/SV_5hbNLq0dceh8TFc Participant Eligibility We are looking for participants who: Are willing to participate in a 6-month intervention to get out of the house and engage in more meaningful activities. Are available to meet on the day the intervention takes place. Are experiencing significant mental health issues. Live in the United States. Are...
We are conducting the study to learn more about the physical and mental effects of infection with human immunodeficiency virus (HIV), aging, substance use and the possible effects of antiretroviral medications (ARVs). Participation in the study may or may not benefit you directly, but may...
The purpose of the study is to gain a deeper understanding of how bacteria cause bleeding gums (gingivitis). Gingivitis is the result of normal dental plaque accumulation, however, gingivitis is easily reversed by cleaning away the dental plaque. The study will evaluate the effects of...
Researchers at Cleveland State University are interested in understanding how individuals who purposely hurt themselves without the intent to die regulate their emotions in daily life. This study involves completing online questionnaires, interviews via videoconferencing or phone, and responding to brief surveys on your cell phone...
The purpose of the study is to investigate the metabolic profiles of people with chronic low back pain and fibromyalgia with people without chronic pain. We are looking for pain-free controls. Study participants will fill out a questionnaire about their medical history and demographic information before the...
This study is testing an investigational drug called frexalimab in adolescents and adults age 12-35 years old with newly diagnosed type 1 diabetes who are on insulin therapy (adults age 18-35 will be enrolled first, followed by 12 to 21-year-olds later in the study). You will...
Help solve the mysteries of the brain. Help us discover future treatments for brain injury and disease. We still do not fully understand how the human brain works. Much of how our brains function and how the parts are organized remains a mystery. Brains are very...
TrialNet is testing rituximab-pvvr and abatacept, one after the other, to learn if using both treatments extend insulin production in people (ages 8-45) who were newly diagnosed with type 1 diabetes (T1D). Each therapy has a history of safety and effectiveness. Rituximab-pvvr is FDA-approved to...
